Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Circulating Tumor Cells (Ctcs) in Metastatic Breast Cancer (MBC): Prognosis, Drug Resistance and Phe
Link ID 34415
Title Circulating Tumor Cells (Ctcs) in Metastatic Breast Cancer (MBC): Prognosis, Drug Resistance and Phe
Url http://www.medscape.com/viewarticle/736308?src=rss
Description Do drug-resistant CTCs have predictive value in metastatic breast cancer? Annals of Oncology
Category Articles > Hematology-Oncology
Keywords
Date Mar 15, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. American Society of Hematology (ASH) 53rd Annual MeetingAmerican Society of Hematology (ASH) 53rd An
  Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. FDA Rescinds Approval of Bevacizumab for Metastatic Breast Cancer
  The FDA has announced that it will take the first steps to remove the indication for bevacizumab (Avastin) in metastatic breast cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. UK NICE Rejects 3 Drugs for Metastatic Colorectal CancerUK NICE Rejects 3 Drugs for Metastatic Color
  Three targeted therapies will not be covered by the National Heath Service for use in patients who progress after first-line chemotherapy. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Fourth AACR Conference on the Science of Cancer Health Disparities (SCHD)Fourth AACR Conference on t
  Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Reduced-Intensity Therapy for Early-Stage Hodgkin Lymphoma
  Is a reduced-cycle chemotherapy plus lower-dose radiotherapy in patients with favorable stage I or II disease as effective as more standard regimens? Journal Watch
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS